Earnings season continues in the medical device industry. Hologic posted its Q3 results this week, and it was a mixed bag. Investors and analysts have questions about future margins. Fast Five hosts Sean Whooley and Danielle Kirsh review the company's performance and the analysts' views. 

The FDA recently granted expanded indication to Teleflex's QuikClot Control+ hemostatic device. The expanded indication may allow Teleflex to target new clinical applications. Find out what the expanded indication covers, how it increases the device's versatility in treating different patient populations, and what executives say. 

Abbott FreeStyle Libre 3 reader is now available and is covered by Medicare. The Fast Five hosts discuss how the FreeStyle Libre 3 reader works and how it pairs with Abbott's latest continuous glucose monitoring sensor. Gain insights into Abbott's pipeline activity and plans for the second half of 2023.

Integra Lifesciences plans to resume manufacturing at its Boston facility just two months after it voluntarily recalled all tissue-related products made at the plant. Whooley explains why the company stopped manufacturing and how it has addressed the problems since the recalls, including the measures taken to strengthen leadership and project management. 

The FDA has labeled Baxter's recall of some infusion pumps as Class I, the most serious kind. Kirsh and Whooley go over the issues behind the recall, how many devices are included and what resolution the company is offering. 

Check out the show notes for links to the stories we discussed today at MassDevice.com/podcast.